Blockade of the IL-12/IL-23 pathway with ustekinumab modulates the composition of the microbiome in lesional skin from psoriasis patients

Tsianakas, A; Baumann, C; Riepe, C; Magnolo, N; Dobrindt, U; Luger, T; Loser, K

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018; 138 (5): S68